Conclusion: Genetic studies have proven to be an effective means of developing our understanding of AD. This knowledge is opening the way for the development of safe and effective therapies based on blocking Ab production, inhibiting its aggregation or accelerating its removal. The genetic data may assist in the identification of individuals predisposed to AD while the neuronal damage is still negligible